DNA interaction of a fluorescent, cytotoxic pyridinimino platinum(II) complex

J Inorg Biochem. 2020 Jan:202:110874. doi: 10.1016/j.jinorgbio.2019.110874. Epub 2019 Oct 21.

Abstract

New pyridinimino complexes of platinum(II) [PtCl2(N^N-R)] (N^N = 2-pyridylmethanimino, R = -(CH2)2O(CH2)2OH, -(CH)2O(CH2)2OCH2Pyr), Pyr = pyren-1-yl) have been prepared. They are characterized by a dioxygenated alkyl side chain and, in one case, by a fluorescent terminal 1-pyrenyl residue. The complexes were characterized by elemental analysis, IR, 1H-, 13C-and 195Pt NMR spectroscopies. For [PtCl2(N^N-(CH2)2O(CH2)2OH] the molecular structure was determined by single crystal X-ray diffraction. The complexes are soluble and stable in DMSO/H2O (80/20, v/v). The pyrenyl terminated compound was tested as antiproliferative agent against selected human cancer cell lines. Comparable cytotoxic effect was obtained on human ovarian carcinoma A-2780 and A-2780cis cells, thus suggesting a certain ability to circumvent cisplatin resistance. The interaction of this complex with DNA was investigated by linear flow dichroism and by spectrophotometric (absorbance and fluorescence) titrations. Both techniques enlightened the presence of a complex mode of interaction with DNA, involving both groove binding and intercalation.

Keywords: Antiproliferative properties; DNA interaction; Groove binding; Intercalation; Pyridinimino platinum(II) complexes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation
  • Cisplatin / pharmacology
  • DNA, Neoplasm / chemistry
  • DNA, Neoplasm / metabolism*
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Fluorescence*
  • Humans
  • Models, Molecular
  • Organoplatinum Compounds / chemistry
  • Organoplatinum Compounds / pharmacology*
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology
  • Pyridines / chemistry
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Organoplatinum Compounds
  • Pyridines
  • pyridine
  • Cisplatin